DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML

NCT00589082 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto